Global Tuberculosis Diagnostics Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Tuberculosis Diagnostics Industry In 2025?

The overall valuation of the tuberculosis diagnostics sector has experienced robust expansion across recent years, with projections indicating an increase from its $2.21 billion standing in 2024 to reach $2.34 billion by 2025, reflecting a steady compound annual growth rate of 5.9%; this upward trajectory observed during the past period stems from several underlying factors, including the escalating prevalence of tuberculosis cases, augmented spending on healthcare provisions, an expansion in the quantity of medical institutions available, and a heightened utilization rate of nucleic acid testing methodologies.

Projections indicate considerable expansion for the tuberculosis diagnostics sector in the coming years, with its valuation set to reach $3.15 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.7%. This upswing during the projection timeframe is fueled by robust governmental backing, a rising number of tuberculosis diagnostic solutions securing FDA clearance, escalating investment in research and development efforts, and the growing challenge posed by drug-resistant tuberculosis strains. Key developments influencing this market trajectory encompass a growing emphasis on next-generation sequencing (NGS) technologies specifically for TB diagnosis, advancements in product offerings, the utilization of t-cell assays to detect TB infection, adoption of artificial intelligence (AI) within tuberculosis diagnostic tools, the proliferation of handheld diagnostic equipment, and increased partnerships forged between governmental bodies and commercial manufacturers.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Which Major Market Drivers Are Shaping The Future Of The Tuberculosis Diagnostics Market?

Accelerating occurrences of tuberculosis, a serious lung affliction transmitted via airborne particles expelled during coughing or sneezing, are consequently bolstering the requirement for tuberculosis diagnostic tools; these diagnostics are crucial for identifying afflicted individuals, enabling quicker recognition and treatment of the condition, a trend evidenced by the fact that the US saw an increase in reported cases from 7,874 in 2021 to 8,300 in 2022, as noted by the Centers for Disease Control and Prevention in March 2023, which directly fuels expansion within the tuberculosis diagnostics sector.

What Are The Major Segment Types Covered In The Tuberculosis Diagnostics Market?

The tuberculosis diagnosticsmarket covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Which Key Trends Are Expected To Influence The Tuberculosis Diagnostics Market In The Coming Years?

A primary driver of growth within the tuberculosis diagnostics market is the proliferation of technological advancements. Leading firms are establishing their market presence by rolling out novel diagnostic approaches, particularly sophisticated point-of-care (POC) techniques that incorporate artificial intelligence. Illustrating this trend, in the month of August 2022, Fujifilm, originating from Japan and known for its medical imaging hardware, formed an alliance with Qure.ai, a United States entity specializing in AI-driven medical imaging software, to debut a cutting-edge POC diagnostic offering. This particular diagnostic technique employs an X-ray apparatus powered by a battery for identifying tuberculosis. Through the application of artificial intelligence, the associated algorithms facilitate highly effective testing protocols, delivering diagnostic solutions characterized by supreme portability, elevated precision, and streamlined operation at the point of care.

Which Key Players Are Driving Competition In The Tuberculosis Diagnostics Market?

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

What Regional Growth Trends Are Shaping The Tuberculosis Diagnostics Market Outlook?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Tuberculosis Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2025, By The Business Research Company

Respiratory Disposables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

Respiratory Devices And Equipment Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795